Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.007 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Atheroma progression in hyporesponders to statin therapyKataoka, Y.; St John, J.; Wolski, K.; Uno, K.; Puri, R.; Tuzcu, E.; Nissen, S.; Nicholls, S.
2015Impact of statins on serial coronary calcification during atheroma progression and regressionPuri, R.; Nicholls, S.; Shao, M.; Kataoka, Y.; Uno, K.; Kapadia, S.; Tuzcu, E.; Nissen, S.
2015Cholesterol efflux capacity and pre-beta-1 HDL concentrations are increased in dyslipidemic patients treated with evacetrapibNicholls, S.; Ruotolo, G.; Brewer, H.; Kane, J.; Wang, M.; Krueger, K.; Adelman, S.; Nissen, S.; Rader, D.
2015Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: insights from AQUARIUSPuri, R.; Nissen, S.; Menon, V.; Shao, M.; Hsu, A.; Bakris, G.; Kastelein, J.; Williams, B.; Armbrecht, J.; Brunel, P.; Kataoka, Y.; Nicholls, S.
2015Near-Infrared spectroscopy enhances intravascular ultrasound assessment of vulnerable coronary plaque: a combined pathological and in vivo studyPuri, R.; Madder, R.; Madden, S.; Sum, S.; Wolski, K.; Muller, J.; Andrews, J.; King, K.; Kataoka, Y.; Uno, K.; Kapadia, S.; Murat Tuzcu, E.; Nissen, S.; Virmani, R.; Maehara, A.; Mintz, G.; Nicholls, S.
2015Plaque vulnerability at non-culprit lesions in obese patients with coronary artery disease: frequency-domain optical coherence tomography analysisKataoka, Y.; Hammadah, M.; Puri, R.; Duggal, B.; Uno, K.; Kapadia, S.; Tuzcu, E.; Nissen, S.; Nicholls, S.
2015Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation StudyKhaliq, A.; Johnson, B.; Anderson, R.; Bavry, A.; Cooper-DeHoff, R.; Handberg, E.; Bairey Merz, C.; Nicholls, S.; Nissen, S.; Pepine, C.
2015Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: rationale and design of the ACCELERATE trialNicholls, S.; Lincoff, A.; Barter, P.; Brewer, H.; Fox, K.; Gibson, C.; Grainger, C.; Menon, V.; Montalescot, G.; Rader, D.; Tall, A.; McErlean, E.; Riesmeyer, J.; Vangerow, B.; Ruotolo, G.; Weerakkody, G.; Nissen, S.